The Discounted Cash Flow (DCF) valuation of Allergy Therapeutics PLC (AGY.L) is (15.76) GBP. With the latest stock price at 10.70 GBP, the upside of Allergy Therapeutics PLC based on DCF is -247.3%.
Based on the latest price of 10.70 GBP and our DCF valuation, Allergy Therapeutics PLC (AGY.L) is a sell. selling AGY.L stocks now will result in a potential gain of 247.3%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.3% - 8.6% | 7.4% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (39.61) - (10.36) | (15.76) |
| Upside | -470.2% - -196.8% | -247.3% |